|
|
Volumn 4, Issue 4, 2001, Pages 192-197
|
|
Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer
a
a
|
|
Author keywords
FAMTX; Neoadjuvant chemotherapy; Scirrhous gastric cancer
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ALLERGIC REACTION;
ALOPECIA;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER SURVIVAL;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE TIME EFFECT RELATION;
DRUG EFFICACY;
DRUG MEGADOSE;
DYSPNEA;
FEMALE;
HAND FOOT SYNDROME;
HISTOPATHOLOGY;
HUMAN;
INFECTION;
KIDNEY FAILURE;
LEUKOPENIA;
MALE;
NAUSEA;
NEUROTOXICITY;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
STOMACH CANCER;
STOMATITIS;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
ADENOCARCINOMA, SCIRRHOUS;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOXORUBICIN;
FEASIBILITY STUDIES;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
METHOTREXATE;
MIDDLE AGED;
NEOADJUVANT THERAPY;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 18244381054
PISSN: 14363291
EISSN: None
Source Type: Journal
DOI: 10.1007/s10120-001-8009-5 Document Type: Article |
|
Times cited : (14)
|
|
References (19)
|
